Effects of polysaccharide intercellular adhesin (PIA) in an ex vivo model of whole blood killing and in prosthetic joint infection (PJI): A role for C5a by Llinos, Harris & Thomas, Wilkinson
 Cronfa -  Swansea University Open Access Repository
   
_____________________________________________________________
   
This is an author produced version of a paper published in :
International Journal of Medical Microbiology
                                                
   
Cronfa URL for this paper:
http://cronfa.swan.ac.uk/Record/cronfa23338
_____________________________________________________________
 
Paper:
AL-Ishaq, R., Armstrong, J., Gregory, M., O’Hara, M., Phiri, K., Harris, L., Rohde, H., Siemssen, N., Frommelt, L.,
Mack, D. & Wilkinson, T. (2015).  Effects of polysaccharide intercellular adhesin (PIA) in an ex vivo model of whole
blood killing and in prosthetic joint infection (PJI): A role for C5a. International Journal of Medical Microbiology
http://dx.doi.org/10.1016/j.ijmm.2015.08.005
 
 
 
 
 
 
 
 
_____________________________________________________________
  
This article is brought to you by Swansea University. Any person downloading material is agreeing to abide by the
terms of the repository licence. Authors are personally responsible for adhering to publisher restrictions or conditions.
When uploading content they are required to comply with their publisher agreement and the SHERPA RoMEO
database to judge whether or not it is copyright safe to add this version of the paper to this repository. 
http://www.swansea.ac.uk/iss/researchsupport/cronfa-support/ 
 Accepted Manuscript
Title: Effects of Polysaccharide Intercellular Adhesin (PIA) in
an ex vivo model of whole blood killing and in prosthetic joint
infection (PJI): A role for C5a
Author: Rand AL-Ishaq Jayne Armstrong Martin Gregory
Miriam O’Hara Kudzai Phiri Llinos G. Harris Holger Rohde
Nicolaus Siemssen Lars Frommelt Dietrich Mack Thomas S.
Wilkinson
PII: S1438-4221(15)30004-7
DOI: http://dx.doi.org/doi:10.1016/j.ijmm.2015.08.005
Reference: IJMM 50967
To appear in:
Received date: 25-7-2014
Revised date: 5-8-2015
Accepted date: 16-8-2015
Please cite this article as: AL-Ishaq, R., Armstrong, J., Gregory, M., O’Hara, M.,
Phiri, K., Harris, L.G., Rohde, H., Siemssen, N., Frommelt, L., Mack, D., Wilkinson,
T.S.,Effects of Polysaccharide Intercellular Adhesin (PIA) in an ex vivo model of whole
blood killing and in prosthetic joint infection (PJI): A role for C5a, International Journal
of Medical Microbiology (2015), http://dx.doi.org/10.1016/j.ijmm.2015.08.005
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
Page 1 of 27
Ac
ce
pte
d M
an
us
cri
pt
1 
 
Effects of Polysaccharide Intercellular Adhesin (PIA) in an ex vivo model of whole blood 1 
killing and in prosthetic joint infection (PJI): a role for C5a 
 2 
 
3 
1
Rand AL-Ishaq, 
1
Jayne Armstrong, 
1
Martin Gregory, 
1
Miriam O’Hara,
 1
Kudzai Phiri, 
1
Llinos G. 4 
Harris, Holger Rohde, Nicolaus Siemssen, Lars Frommelt 
1,2
Dietrich Mack, 
1
Thomas S. 5 
Wilkinson 6 
 7 
1
Institute of Life Science, First Floor, Room 137, Microbiology and Infectious Disease, 8 
Swansea University, Singleton Park, SA2 8PP 9 
2Bioscientia Labor Ingelheim, Institut für Medizinische Diagnostik GmbH, Mikrobiologie 10 
Konrad-Adenauer-Straße 17, 55218, Ingelheim 11 
 12 
 13 
Running title : Role for C5a in prosthetic joint infection 14 
Key Words : Polysaccharide Intercellular Adhesin, Prosthetic Joint Infection, Biofilm, Whole 15 
Blood, Complement C5a, Staphylococcus epidermidis
 16 
Word Count : Introduction to the end of Discussion is 2824 17 
18 
Page 2 of 27
Ac
ce
pte
d M
an
us
cri
pt
2 
 
 18 
Footnote page 19 
Conflict of Interest 20 
To the best of our knowledge ALL the authors confirm that they do not have any commercial 21 
or other association that might pose a conflict of interest.  22 
 
23 
Financial Support 24 
This work was funded by a fellowship awarded to Dr Rand AL-Ishaq by the Iraqi 25 
Government. 26 
 
27 
Previous meetings 28 
Part of the work was presented at the Staph GBI 2011 Conference in Edinburgh in an oral 29 
presentation by RAI (www.roslin.ed.ac.uk/staph-gbi2011/programme/) 30 
 31 
Corresponding author details 32 
Thomas S Wilkinson 33 
Institute of Life Science 34 
Fifth Floor, Room 503
 
35 
Microbiology and Infectious Disease 36 
Swansea University 37 
Singleton Park 38 
SA2 8PP 39 
 40 
E-mail: t.s.wilkinson@swansea.ac.uk
 
41 
Phone: 0044-(0)1792-29501842 
Page 3 of 27
Ac
ce
pte
d M
an
us
cri
pt
3 
 
 43 
Abstract
 
44 
Background: A major complication of using medical devices is the development of biofilm-45 
associated infection caused by Staphylococcus epidermidis where Polysaccharide 46 
Intercellular Adhesin (PIA) is a major mechanism of biofilm accumulation. PIA affects innate 47 
and humoral immunity in isolated cells and animal models. Few studies have examined 48 
these effects in prosthetic joint infection (PJI).   49 
Methods: This study used ex vivo whole blood modelling in controls together with matched-50 
serum and staphylococcal isolates from patients with PJI.  51 
Results: Whole blood killing of PIA positive S. epidermidis and its isogenic negative mutant 52 
was identical.  Differences were unmasked in immunosuppressed whole blood pre-treated 53 
with dexamethasone where PIA positive bacteria showed a more resistant phenotype. PIA 54 
expression was identified in three unique patterns associated with bacteria and leukocytes, 55 
implicating a soluble form of PIA.  Purified PIA reduced whole blood killing while increasing 56 
C5a levels.  In clinically relevant staphylococcal isolates and serum samples from PJI 57 
patients; firstly complement C5a was increased 3-fold compared to controls; secondly, the 58 
C5a levels were significantly higher in serum from PJI patients whose isolates preferentially 59 
formed PIA-associated biofilms. 60 
Conclusions: These data demonstrate for the first time that the biological effects of PIA are 61 
mediated through C5a in patients with PJI.  62 
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 63 
Introduction
 64 
 
65 
Current estimates suggest that the number of implanted joint prostheses will continue to 66 
increase significantly over the next 20 years (Kurtz et al., 2007). Joint prostheses reduce 67 
pain, replace lost function and improve quality of life. In striking contrast prosthetic joint 68 
infection (PJI) is a serious complication which occurs at a frequency of 1-2% after joint 69 
replacement, with a mortality rate of 1-3% resulting in an increased financial burden to the 70 
healthcare system. The major causative organisms in PJI are Staphylococcus epidermidis and 71 
S. aureus, accounting for 30-43% and 12-23% respectively (Trampuz and Zimmerli, 2005). 72 
The ability of staphylococci to adhere and grow on biomaterial surfaces to form a biofilm is 73 
of mechanistic importance for the development of a PJI.   74 
 75 
Polysaccharide intercellular adhesin (PIA) is important for biofilm accumulation in S. 76 
epidermidis biomaterial associated infection (Rohde et al., 2010). PIA is a linear 77 
polysaccharide of β-1,6-N-acetylglucosamine containing positive charges due to 78 
deacetylated amino groups and negative charges due to O-succinoyl ester residues (Mack et 79 
al., 1996). PIA is produ ed by the icaABDC locus which is composed of the operon encoding 80 
a membrane bound enzyme complex (Gerke et al., 1998; Heilmann et al., 1996; Ziebuhr et 81 
al., 1997).  PIA has been shown to have effects on innate immunity. In isolated cellular 82 
models PIA inhibits phagocyte killing (Barrio et al., 2000; Vuong et al., 2004), by mechanisms 83 
thought to involve the combined inhibition of C3b and IgG deposition on the bacterial 84 
surface  (Kristian et al., 2008) while also decreasing antimicrobial peptide action (Vuong et 85 
al., 2004). In addition, PIA modulates cytokine production (Schommer et al., 2011; Stevens 86 
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et al., 2009) through mechanisms that may partly involve TLR-2.  Consistent with this, in vivo 87 
models, suggest that PIA biofilm formation was related to persistent bacteremia in neonates 88 
in intensive-care units (Dimitriou et al., 2011) and appeared as a major virulence factor in 89 
biomaterial-associated infection model in rats and mice (Rupp et al., 2001; Rupp et al., 90 
1999a; Rupp et al., 1999b) and in Caenorhabditis elegans (Begun et al., 2007).  91 
 
92 
Recently, the importance of complement activation in staphylococcal infections has become 93 
apparent in experimental infection (von Kockritz-Blickwede et al., 2010) and in human 94 
whole blood (Skjeflo et al., 2014). More specifically, staphylococcal biofilm matrices have 95 
been implicated in complement activation. Here PIA from S. epidermidis has been shown to 96 
modulate complement binding and activation in opsonised human neutrophils (Kristian et 97 
al., 2008), and induction of complement C5a has been demonstrated in whole blood 98 
(Fredheim et al., 2011), human serum (Satorius et al., 2013) and neonatal whole blood 99 
(Granslo et al., 2013).   100 
 
101 
To date however, it is unclear i) what the necessary infecting doses are for whole blood 102 
production of complement C5a; ii) whether similar responses exist in patients with PJI; iii) 103 
how PIA interacts with host cells; iv) whether such responses may be useful for early 104 
diagnosis. Here we confirm the importance of immunosuppression for PIA induced 105 
complement fragment C5a production. We identify novel PIA structures that contribute to 106 
interactions with leukocytes. Furthermore we identify high levels of C5a in sera from PJI 107 
patients exposed to isolates of S. epidermidis producing PIA dependent biofilms.  108 
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 109 
Methods 110 
 
111 
Bacterial strains and culture conditions 112 
Archived and sequenced S. epidermidis strains were isolated as described in previous studies 113 
(Rohde et al., 2007) and form part of our online staphylococcal database (Sheppard, 2012). 114 
Specifically, S. epidermidis 1457 was isolated from a central venous catheter infection (Mack 115 
et al., 1992). The isogenic mutant S. epidermidis 1457-M10 (M10) was produced by 116 
transposon mutagenesis of the icaADBC locus as described previously (Mack et al., 1999). 117 
 
118 
Bacterial culture 119 
One colony of S. epidermidis was inoculated into tryptic soy broth (TSB) and incubated 120 
overnight at 37°C. Then 1 ml of overnight culture was centrifuged at 9447g and the 121 
supernatant removed. Pellets were resuspended by flicking and 1 ml of Iscove’s Modified 122 
Dulbecco’s Medium (IMDM) added prior to one further wash. Optical density was measured 123 
at 600nm and adjusted to OD600 = 0.1 giving an S. epidermidis stock concentration of ~1 x 124 
10
7
 cfu/ml. 125 
 126 
Serum samples 127 
Serum from healthy volunteers was isolated using the vacuette blood collection system 128 
(5ml-9ml) on the day of the experiment. Volunteers gave their consent and the work is one 129 
of the projects (13/WA/0190) assessed by the local ethics committee (Wales Rec 6) at 130 
College of Medicine, Swansea University. Samples from PJI patients included sixty five 131 
matched serum and staphylococcal isolate pairs together with 4 study matched controls 132 
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that received a prosthetic joint but did not contract a PJI. Patients gave written informed 133 
consent to participate in the study in accordance with the requirements at ENDO clinic, 134 
Hamburg. (Rohde et al., 2007; Rohde et al., 2008.; Rohde et al., 2005).  135 
 136 
Antibodies 137 
Anti-human CD11b (5µg/ml), anti-human CD18 (20µg/ml), anti-human CD16 (20µg/ml) and 138 
isotype control (20µg/ml) were all purchased from Biolegend.  139 
 140 
Whole blood killing 141 
Whole blood was collected from healthy volunteers using the vacuette blood collection 142 
system containing sodium heparin (5ml-9ml) on the day of the experiment. Volunteers gave 143 
their consent and the work is one of the projects (13/WA/0190) assessed by the local ethics 144 
committee (Wales Rec 6) at College of Medicine, Swansea University. One millilter of blood 145 
was added to 1.5ml microcentrifuge tubes before 10μl of S.epidermidis 1457 or 1457-M10 146 
stock was added (to give ~2 x 10
5
cfu/ml final). Infected blood was incubated with rotation at 147 
10rpm at 37˚C for different time periods according to experiment (0-24 hours). Viable 148 
counts were assessed by g ntle lysis of leukocytes in 0.1% Triton X100 for 1 min to release 149 
intracellular bacteria. Then suspensions were diluted and plated on TSB agar. Plates were 150 
incubated at 37°C overnight. The next day colonies were counted and viable counts 151 
estimated. Whole blood remaining at each time point was centrifuged at 9447g for 5 min 152 
and the platelet poor plasma / serum removed and stored at -20°C prior to ELISA analysis.  153 
 154 
155 
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 155 
ELISA 156 
Duoset ELISAs (R and D systems, Abingdon) for human C5a, IL-8, TNFα and IL-1β, were 157 
carried out according to the manufacturers’ instructions. Healthy volunteers’ sera were 158 
diluted 1/10 and patient sera 1/20.  159 
 
160 
Immunocytochemistry 161 
One colony of S. epidermidis 1457 was used to establish an overnight pre-culture in TSB 162 
(without glucose). The following day a 1:100 dilution was made into either; i) untreated 163 
whole blood iii) whole blood pre-treated with dexamethasone (0.1-1μM) for 18 hours; iii) 164 
whole blood pre-treated with cytochalasin D (5µg/ml) for 30 minutes. Cultures were 165 
incubated for 0-24 hours. Then, 200µl of whole blood was added to 3ml of red blood cell 166 
(RBC) lysis buffer (15mM ammonium chloride in 0.1M TrisHCl, pH, 7.5) for up to 10min. 167 
Cytospin preparations were prepared and blocked with 200μl 1% BSA for 1 hour, then 168 
washed X3 with PBS. Then 200μl of rabbit anti-PIA antiserum (diluted 1:50) was applied, the 169 
slides covered and after 30 minutes the slides washed X3 with PBS. Then slides were stained 170 
with fluorescein–conjugated anti-rabbit IgG (Alexa flour 488, diluted 1:100) and propidium 171 
iodide (1μg/ml), covered and incubated for 30 minutes. Slides were washed X3 with PBS 172 
then 25µl of vectashield® hardset™ (Vector Laboratories, Peterborough) was added, a 173 
coverslip added gently and the preparation left in the fridge to harden. Slides were 174 
examined using an Axiovert epifluorescent microscope. 175 
 176 
Structural analysis of WB leukocytes, PIA and S. epidermidis were analysed using confocal 177 
microscopy. Here slight modifications to the whole blood killing assays and 178 
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immunocytochemistry were needed to produce labelled cells. Firstly, S. epidermidis 1457 179 
pre-cultures were prepared as above and were stained with syto-9 (20μM) for 1 hour. 180 
Excess syto-9 was removed by centrifugation at 9447g for 5 minutes then resuspended in 181 
PBS. The bacterial suspension was washed a further 5 times.  Then 10μl of stained S. 182 
epidermidis 1457 was used to infect whole blood as previously described. Following whole 183 
blood killing and RBC lysis leukocyte membranes were stained with Cell Mask ™ deep red 184 
(Life Technologies, diluted 1:100) for 10 minutes. Then cytospins were prepared as 185 
previously described above. Slides were stained as above with two modifications; i) 186 
propidium iodide was removed and ii) anti-rabbit IgG (alexa 594) was used to detect the PIA 187 
antibodies. Once slides were complete confocal laser scanning microscopy (Zeiss) analysed 188 
3-5 fields per slide. Each field imaged 8-20 sections of 1-1.5μm thickness. To maintain 189 
consistency with the previous immunocytochemistry colours, images were pseudo-coloured 190 
purple for cell mask (cell membranes), red for syto-9 (Bacteria) and green for alexa 594 191 
(PIA).   192 
 193 
Biofilm assay 194 
A single bacterial colony was picked from a blood plate and suspended in 5 ml of TSB broth 195 
and then incubated at 37°C for 18 hours with shaking at 200rpm. The next day this pre-196 
culture was diluted 1:100 with fresh TSB, then 200μl aliquoted into each well of a NUNC 96-197 
well plate. The plate was incubated for 18 hours at 37˚C without shaking. On the next day 198 
the media was carefully removed and the wells washed 3X with 200μl PBS and 150μl of 199 
Bouin´s fixative was added to each well prior to incubation for 15 minutes. Then Bouin´s 200 
fixative was removed and the wells washed once with PBS and left to air dry. Adherent 201 
biofilms were then stained with 150μl of crystal violet for 5 minutes, and then washed X5 202 
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under running tap water and left it to air dry. The optical density of biofilms was measured 203 
at 570 nm using an Omega Fluo Star plate reader. Biofilm mechanism was investigated by 204 
treating mature biofilms with proteinase K (1mg/ml) or sodium periodate (40mM), to digest 205 
protein dependent and PIA dependent biofilms respectively, for 24 hours prior to washing. 
 
206 
 207 
Statistical Analysis 208 
Pairwise comparisons were calculated using the unpaired Student’s t-test. Multiple dataset 209 
comparisons were subjected to a non-parametric Kruskal-Wallis test and included a Dunn’s 210 
post-hoc test. Results were considered significant if P<0.05. 211 
212 
Page 11 of 27
Ac
ce
pte
d M
an
us
cri
pt
11 
 
 212 
Results 213 
To investigate the effects of PIA on immune cells we developed an ex vivo model of whole 214 
blood (WB) infection. Here stationary-phase S.epidermidis 1457 which produce a PIA 215 
dependent biofilm, or an isogenic mutant 1457-M10 which does not form biofilm were 216 
added to freshly drawn WB. Dose and time course analysis over the first 3 hours of infection 217 
suggested to us that there was very little difference in the ability of WB to kill S. epidermidis 218 
1457 compared to 1457-M10 (Data not shown). Similarly at 6 hours post infection there was 219 
no significant difference in killing response between S. epidermidis 1457 and 1457-M10 220 
(Figure 1). Antibody blocking studies (Figure 1) demonstrated the killing was CR-3 221 
dependent as antibodies against CD11b and CD18 could completely inhibit killing, unlike an 222 
antibody against CD16.  223 
 224 
In contrast under immunosuppressive conditions, pre-incubation of whole blood with 225 
dexamethasone resulted in a dose dependent decrease in the killing of S. epidermidis 1457 226 
compared to its isogenic mutant which reached significance at 1nM dexamethasone (Figure 227 
2A). Thus immunosuppression unmasks resistance to killing in PIA positive S. epidermidis.  228 
Killing of S. epidermidis was dependent on actin assembly during phagocytosis (Goddette 229 
and Frieden, 1986; Shoji et al., 2012) as treatment with cytochalasin D demonstrated could 230 
block killing of both strains (Figure 2A).  To confirm the presence of PIA under 231 
immunosuppressive conditions we used immunocytochemistry.  PIA expression in S. 232 
epidermidis 1457 over the first 6 hours of growth demonstrated no growth or PIA in WB 233 
alone. In contrast, WB pre-incubated with dexamethasone showed bacterial growth and PIA 234 
production. Complete inhibition of leukocyte phagocytosis with cytochalasin D resulted in 235 
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dramatic growth and PIA expression. These experiments clearly demonstrate that PIA 236 
expression could be detected in immunosuppressed WB but not in healthy untreated WB. 237 
However bacterial growth and PIA expression in immunosuppressed WB is markedly 238 
reduced compared to PIA positive cultures of S. epidermidis 1457 incubated in TSB at similar 239 
times (Supplementary Figure 1A-D). 
 240 
 
241 
We further investigated the localisation of PIA expression in immunosuppressed WB using 242 
immunocytochemistry and confocal microscopy (Figure 3). This work revealed three 243 
patterns of PIA expression and localisation (Figure 3B-G) including; i) ‘beads on a 244 
string/bridges’ defined by single bacteria interspaced by PIA cable or string-like structures 245 
(Figure 3B and C); ii) ‘clumps’ defined by dense aggregates of PIA associated with bacteria 246 
(Figure 3D and E); and iii) ‘caps’ defined by small aggregates of PIA associated with smaller 247 
bacterial numbers expressed on one side of a leukocyte (Figure 3F and G). 
 
248 
 249 
Further investigation of temporal changes at later time-points proved difficult due to 250 
decreases in leukocyte viability. We were intrigued by the intricate patterning of PIA (Figure 251 
3) and we therefore modelled the effects of later time-points by using PIA purified from S. 252 
epidermidis 1457 in a low endotoxin environment (Supplementary methods). Then,  WB was 253 
incubated with PIA prior to infection with PIA deficient S. epidermidis 1457-M10 and 254 
determination of killing and cytokine production (Figure 4A-D). At 6 hours post infection 255 
1457-M10 were cleared vigorously from untreated blood (Figure 4A). In striking contrast WB 256 
exposed to PIA could not kill to the same degree, unlike blood incubated with negative 257 
vehicle control (M10-see supplementary methods) (Figure 4A). Thus PIA inhibited killing of 258 
S.epidermidis 1457-M10 by WB. Humoral responses in these samples showed that 259 
Page 13 of 27
Ac
ce
pte
d M
an
us
cri
pt
13 
 
complement fragment C5a was significantly increased in PIA treated WB compared to 260 
control M10 and untreated control (Figure 4B). Cytokine analysis showed similar increases 261 
in IL-8 (Figure 4C) but not IL-1β (Figure 4D) or TNFα and IL-10 (data not shown). In 262 
uninfected controls, PIA induced C5a in the absence of S. epidermidis 1457 and was not 263 
significantly different from infected responses (Black bars, Figure 4B). PIA produced a small 264 
but not significant induction of IL-8 and IL-1β responses in the absence of S. epidermidis 265 
1457 compared to control M10 or blood alone. Thus at this time point C5a was dependent 266 
on PIA whereas the cytokines were dependent on PIA and infection. Consistent with this, 267 
serum isolated from healthy volunteers showed a similar spectrum of responses (Figure 5A) 268 
with PIA inducing C5a production unlike control M10 and untreated control. To investigate 269 
the specificity of the response we digested PIA (or M10) with dispersin B, a hexosaminidase 270 
shown to breakdown PIA (Figure 5B-D). Here dispersin B could completely inhibit PIA 271 
induced C5a to the levels of control M10 confirming the specificity of the effect (Figure 5B).  
 
272 
 
273 
Finally we investigated the relationship between C5a levels in serum and biofilm producing 274 
staphylococcal isolates from patients with prosthetic hip and knee joint infections archived 275 
from a previous study (Rohde et al., 2007). Firstly we confirmed that there was no 276 
difference in the C5a levels in healthy volunteers and the 4 non-PJI age matched patients. 277 
We therefore included all these in our control group when comparing the 65 PJI patients. 278 
Here C5a levels were higher (3-fold) in patient samples compared to controls (Figure 6A). 279 
This difference was independent of the causative organism as patients infected with S. 280 
epidermidis, S. capitis, S. aureus and S. lugdunensis all showed similar C5a serum levels 281 
compared to controls (Figure 6B). We performed further experiments on the larger group of 282 
S. epidermidis isolates to investigate the influence of biofilm (n=43, Figure 7A). We found 283 
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that 26 of the 43 S. epidermidis isolates formed biofilm (OD570 > 0.1) and their mechanism 284 
of biofilm formation was investigated (Figure 7A) by digesting mature biofilms with 285 
proteinase K or sodium periodate that digest protein and PIA dependent biofilms 286 
respectively. These digestions demonstrated that of 26 biofilm positive isolates, 6 were PIA 287 
dependent, 7 were protein dependent and 13 were dependent on PIA and protein (Figure 288 
7A). Then the C5a data (Figure 6B) was organised according to biofilm mechanism of the 289 
infecting isolate (Figure 7B). Strikingly, C5a levels in serum from patients exposed to biofilm 290 
forming isolates was higher compared to serum from patients exposed to biofilm negative 291 
isolates. Furthermore, C5a levels were significantly higher in serum samples from patients 292 
exposed to isolates producing PIA dependent biofilms compared to serum from patients 293 
exposed to biofilm negative isolates (Figure 7B).  294 
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 295 
Discussion 296 
 
297 
The current study extends our previous observations on the importance of C5a (Conway 298 
Morris et al., 2009; Morris et al., 2011) in medical device related infection, namely ventilator 299 
associated pneumonia, to PIA dependent biofilm formation in PJI. Here we demonstrate; i) 300 
the advantage of an ‘immunosuppressed’ host for PIA production in WB; ii) clear 301 
interactions between S. epidermidis-derived  PIA and WB leukocytes, with three distinct 302 
morphological patterns; iii) PIA-induced C5a in human WB and serum; iv) increased C5a in 303 
serum from PJI compared to controls; and finally v) Increased C5a in serum from PIA 304 
dependent PJI compared to biofilm negative PJI. To our knowledge this is the first 305 
demonstration of a link between PIA dependent biofilms and C5a in clinical samples.  306 
  307 
Comparison of whole blood killing of PIA positive and PIA negative S. epidermidis could not 308 
detect differences between strains. This was rather surprising considering similar 309 
experiments in isolated cell systems showing that PIA could protect against antimicrobial 310 
peptide killing and neutrophil killing (Vuong et al., 2004). Clearly killing in the whole blood 311 
environment is so rapid that PIA production is delayed. Only when phagocyte efficiency was 312 
reduced with dexamethasone was a more resistant phenotype unmasked in PIA positive S. 313 
epidermidis. In this model dexamethasone produced a global reduction in cytokines 314 
including IL-8 (data not shown). This has previously been shown to control neutrophil 315 
activation and is a strong candidate for the mechanism of suppression in this model (Hartl et 316 
al., 2007). Others have suggested that dexamethasone causes suppression of neutrophil 317 
phagocytosis (Bober et al., 1995) and free radical release (Liu et al., 2014). These results are 318 
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consistent with the increased risk of biofilm infections in immunocompromised patients 319 
(Weisser et al., 2010) and the immunosuppressive conditions produced during the foreign 320 
body response following the implantation of a medical device (Higgins et al., 2009; Wagner 321 
et al., 2004; Wagner et al., 2003). 
 
322 
 323 
Our current model of the temporal changes that occur during biofilm infection consists of 324 
two stages. In the first stage ‘immunosuppression’ leads to a survival advantage in S. 325 
epidermidis expressing PIA. Here we suggest that PIA is bound to both S. epidermidis and 326 
leukocytes which may further reduce phagocytic efficiency as demonstrated previously 327 
(Kristian et al., 2008; Schommer et al., 2011). The first stage is immunosuppression and PIA 328 
dependent but independent of C5a. Then, in the second stage, having established 329 
colonisation of the host, PIA expressing S. epidermidis further produce PIA resulting in 330 
increased PIA levels also capable of binding leukocytes and serum components at sufficient 331 
concentration to activate C5a. We have previously demonstrated the importance of C5a in 332 
promoting a state of leukocyte dysfunction defined by decreased neutrophil phagocytosis 333 
that is phosphoinositide-3-kinase and CD88 dependent (Conway Morris et al., 2009; Morris 334 
et al., 2011). 335 
 
336 
We identified three populations of PIA; i) ‘beads on a string/bridges’ defined by single 337 
bacteria interspaced by PIA cable or string-like structures ii) ‘clumps’ defined by dense 338 
aggregates of PIA associated with bacteria and iii) ‘caps’ defined by small aggregates of PIA 339 
associated with smaller bacterial numbers expressed on one side of a leukocyte. Such 340 
morphologies have not been identified in contact with leukocytes previously but are 341 
consistent with structures produced in PIA-dependent biofilm formation and remain distinct 342 
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from structures produced in biofilms produced by accumulation associated protein (Aap) 343 
and extracellular matrix binding protein (Ebmp) (Schommer et al., 2011). Support for these 344 
structures is strengthened by a recent publication confirming the ability of PIA to form self-345 
associations and entanglements in addition to binding to other proteins (e.g albumin) in 346 
biological fluids (Ganesan et al., 2013). 
 347 
 
348 
Purified PIA had intriguing biological properties that could induce C5a and inhibit WB killing. 349 
Purified PIA from S. epidermidis has previously been identified as modulating complement 350 
binding and activation in opsonised human neutrophils (Kristian et al., 2008), whole blood 351 
(Fredheim et al., 2011), human serum (Satorius et al., 2013) and neonatal whole blood 352 
(Granslo et al., 2013). Our data is consistent and extends these findings demonstrating that 353 
PIA may disintegrate from or for a ‘bridge’ between the bacterial biofilm leukocytes which is 354 
consistent with inhibition of opsonisation shown previously (Kristian et al., 2008). 355 
 356 
The constitutive levels of C5a in healthy volunteers are consistent with other studies (Kunkel 357 
et al., 1983; Stove et al., 1996; Tayman et al., 2011). However, addition of PIA to serum from 358 
healthy volunteers generat d a threefold induction of C5a (from 20-60ng/ml) compared to 359 
control. The amount of C5a induced by PIA appears more variable and model dependent as 360 
Freidheim and co workers generated 8 fold increases (23-162ng/ml (2-16nM)) in C5a in 361 
response to 2µg/ml PIA for 30 minutes whereas Satorius et al generated 1 fmol/cm
2
/s in 362 
response to PIA biofilms (Fredheim et al., 2011; Satorius et al., 2013). This current study 363 
generated 60ng/ml (~6nM) in 90 minutes. Taken together these studies and our own 364 
suggest that 60-480ng/ml (6-48nM) of C5a may be produced in 90 minutes in a whole blood 365 
/ serum environment confirming the potential for C5a generation in response to PIA. Our 366 
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serum data in patients with PJI confirmed this potential demonstrating similar 3-fold 367 
increases in C5a levels over healthy volunteer controls (20-55ng/ml).  Indeed there was a 368 
striking consistency between C5a levels in the WB killing model (Figure 4B), healthy 369 
volunteer serum induced by PIA (Figure 5) and patient infected with S. epidermidis 370 
producing PIA dependent biofilms (Figure 6) alluding to the relevance of the effect. 371 
However, PIA levels are unlikely to rise to biologically active levels (10-30µg/ml) in healthy 372 
volunteers due to rapid clearance of S. epidermidis in whole blood.  
 
373 
 374 
Sub-group analysis of PJI serum organised by biofilm mechanism showed a significant 375 
difference between C5a levels from patients whose isolates were biofilm negative (42ng/ml) 376 
compared to PIA dependent (55ng/ml). To our knowledge this is the first study to 377 
demonstrate that C5a may differentiate between non-biofilm and different types of biofilm 378 
in PJI. However, pharmacokinetic simulations exploring the role of C5a in central venous 379 
catheter infection suggest that sufficient C5a could not be generated despite complete 380 
coverage of the catheter with biofilm (Satorius et al., 2013) or could be limited by diffusion 381 
distances (Conrad et al., 2013).  Clearly the amount of C5a generated in the PJI patients in 382 
this study is more than sufficient to cause a biological response, such as the inhibition of 383 
killing demonstrated here (Figure 3A). It remains unclear in our study about the proportional 384 
contribution by PIA [to C5a production] although there at least a 13ng/ml increase in serum 385 
C5a between patients with PIA dependent biofilm isolates compared to biofilm negative 386 
isolates. This is consistent with results from Granslo and colleagues who showed that PIA 387 
biofilm produced stronger complement activation than non-PIA biofilm in neonatal late-388 
onset sepsis (Granslo et al., 2013). More generally, C5a is elevated in Pneumococcal 389 
meningitis (Woehrl et al., 2011), Sepsis (Nakae et al., 1994; Yan and Gao, 2012), Dengue 390 
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hemorrhagic fever (Wang et al., 2006), pneumonia (Kiehl et al., 1997), and spontaneous 391 
bacterial peritonitis (Frances et al., 2007). 392 
 
393 
Finally we identify three limitations that guard against over-interpretation of our results. 394 
Firstly we were unable to block PIA induced injury with a C5a blocking antibody (data not 395 
shown) suggesting that other mediators may be involved (e.g. C3a, C4a). Secondly, attempts 396 
to measure PIA in the patient sera through an in house ELISA were unsuccessful however 397 
our previous work on the same sera did confirm higher titers in patients infected with 398 
icaABDC positive strains (1:20000-36000) compared to icaABDC negative and controls 399 
(1:2000-6000)(Rohde et al., 2008.; Rohde et al., 2005). In addition the presence of PIA could 400 
be masked by naturally occuring anti-PIA antibodies and the sensitivity of our ELISA. Finally 401 
C5a is a particularly labile molecule and its degradation product C5a-DES-ARG might be a 402 
more realistic biomarker as we have suggested in previous work (Conway Morris et al., 403 
2009). Our observation that levels of C5a in healthy volunteer controls and controls from 404 
patients who had received a prosthetic joint suggests that stability is likely not a problem 405 
here.  
 
406 
407 
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 407 
Figure Legends 408 
 
409 
Figure 1: Whole blood killing of S. epidermidis 1457 and 1457-M10 in untreated whole 410 
blood
 
411 
One millilitre of whole blood was incubated with S. epidermidis (final concentration 2 x 412 
10
5
/ml) 1457 or 1457-M10 for 6 hours prior to release of intracellular bacteria by gentle 413 
lysis, serial dilution and plating. Colony counts were determined following incubation at 414 
37°C overnight. Hatched lines compare treatments in 1457-M10 and solid lines compare 415 
treatments in 1457. Results are expressed as mean ± SEM (n=4) of S. epidermidis (cfu/ml). * 416 
represents significant differences at P<0.05
 
417 
 
418 
 
419 
Figure 2: Whole blood killing and PIA expression from S. epidermidis incubated in 420 
dexamethasone treated whole blood 421 
(A) Whole blood was pre-incubated for 18 hours with dexamethasone (0-1nM), pre-422 
incubated for 30 minutes with cytochalasin D (5µg/ml) or left untreated prior to adding S. 423 
epidermidis (final concentration 2 x 10
5
/ml) 1457 or 1457-M10. Results are expressed as 424 
mean ± SEM (n=4) of S. epidermidis (cfu/ml). * represents significant differences at P<0.05.  425 
(B-D)    S. epidermidis 1457 was incubated with; (B) untreated whole blood, (C) whole blood 426 
pre-treated with dexamethasone (1μM), or (D) whole blood pre-treated with cytochalasin D 427 
(5μg/ml) for 6 hours. Samples were cytospun onto microscope slides and stained with rabbit 428 
anti-PIA antibody. Preparations were washed before an Alexa fluor 488-conjugated anti-429 
rabbit IgG was added with propidium iodide counterstain. Slides were visualised under an 430 
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Axiovert epifluorescent microscope. Results are representative images from at least 3 431 
experiments. Here PIA is stained green and DNA from bacteria or leukocyte nuclei stained 432 
red with original magnification (X1000). 433 
 434 
Supplementary Figure 1: PIA expression from S. epidermidis in tryptic soy broth
 
435 
One colony of S. epidermidis 1457 was incubated in TSB-glucose overnight (t=0). Then a 436 
1:100 dilution was made into; TSB – glucose (A-B) or TSB + glucose (C-D), and incubated for 437 
3 and 5 hours. Samples were cytospun onto microscope slides and stained with rabbit anti-438 
PIA antibody. Preparations were washed before an Alexa fluor 488-conjugated anti-rabbit 439 
IgG was added with propidium iodide counterstain. Slides were visualised under an Axiovert 440 
fluorescent microscope. Results are representative images from at least 3 experiments 441 
where PIA is green and S. epidermidis bacteria are red with original magnification (X1000). 442 
 
443 
Figure 3: PIA expression from S. epidermidis incubated in dexamethasone treated whole 444 
blood 445 
Structural analysis of WB leukocytes, PIA and S. epidermidis were analysed using confocal 446 
microscopy. Here whole blood killing assays were carried out with labelled S. epidermidis 447 
1457. Firstly, S. epidermidis 1457 pre-cultures were prepared and were stained with syto-9 448 
(20μM) for 1 hour with the excess syto-9 removed by multiple centrifugation and washing. 449 
Stained S. epidermidis 1457 was used to infect whole blood as previously described. 450 
Following whole blood killing and RBC lysis, leukocyte membranes were stained with Cell 451 
Mask ™ deep red (Life Technologies, diluted 1:100) for 10 minutes. Then cytospins were 452 
prepared as previously described in materials and methods. Slides were stained with rabbit 453 
anti-PIA for 1 hour followed by anti-rabbit IgG (alexa 594) for a further hour. Slides were 454 
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washed, mounted in vectashield® hardset™ and allowed to harden overnight. Then confocal 455 
laser scanning microscopy (Zeiss) analysed 3-5 fields per slide. Each field images 8-20 456 
sections of 1-1.5μm thickness. Results are representative images from at least 3 457 
experiments. To maintain consistency with the previous immunocytochemistry colours, 458 
images were pseudo-coloured purple for cell mask (cell membranes), red for syto-9 459 
(Bacteria) and green for alexa 594 (PIA). 460 
 461 
Figure 4: Effect of purified PIA on whole blood parameters 462 
Healthy volunteer whole blood was pre-incubated with PIA (10-60µg/ml) or negative control 463 
(M10) for 3 hours prior to infection with S. epidermidis (final concentration 2 x 10
5
/ml) for 6 464 
hours.  Whole blood suspensions were subjected to gentle RBC lysis, serial dilution and 465 
plating. (A) Colony counts were determined following incubation at 37°C overnight. Results 466 
are expressed as mean ± SEM. Remaining suspensions were centrifuged at 9447g for 5 min 467 
and the supernatants analysed for (B) C5a, (C) IL-8, (D) IL-1β. Results are expressed as mean 468 
± SEM of the cytokine measured (n=4). * represents significant differences at P<0.05 469 
 470 
Figure 5: Effect of purified PIA on C5a levels in healthy volunteer serum
 471 
(A) Serum from healthy volunteers was incubated with PIA (60µg/ml) for 90 minutes before 472 
being stored immediately at -80°C prior to C5a ELISA. (B) Specificity was investigated by pre-473 
incubating PIA or vehicle control (M10) with dispersin B (10μg/ml) on rotation at 10rpm for 474 
30 minutes at 37°C prior to incubation with serum. Confirmation of Dispersin B activity was 475 
investigated by immunocytochemistry in cytospin preparations of S. epidermidis 1457 which 476 
were untreated (C) or treated with dispersin B at 10μg/ml (D) for 30 minutes prior to 477 
staining for PIA (Green) and bacteria (red). 478 
Page 23 of 27
Ac
ce
pte
d M
an
us
cri
pt
23 
 
Results are expressed as the mean ± SEM (n=6-10) C5a response in healthy volunteer sera. * 479 
and ** represent significant differences at P<0.05 and P< 0.01 respectively.
 480 
 
481 
Figure 6: C5a levels in serum from controls and patients with PJI 482 
Archived serum from controls and patients with PJI were assayed for C5a levels. (A) C5a 483 
levels in controls and patients with PJI. (B) C5a levels in controls and patients with PJI 484 
catagorised by species of the infecting isolate. Results are expressed as the mean ± SEM C5a 485 
response in healthy volunteer (n=10) and sera from PJI patients (n=65). **, *** and **** 486 
represent significant differences at P<0.01, P< 0.001 and P<0.0001 respectively. 487 
 
 488 
Figure 7: C5a levels in patients with PJI determined by mechanism of biofilm accumulation 
 
489 
Archived serum from healthy volunteers and patients with PJI were assayed for C5a levels. 490 
(A) Schematic representation of biofilm forming properties of S. epidermidis PJI isolates 491 
(n=43). All S. epidermidis isolates were grown in NUNC 96 well microtiter plates for 24 492 
hours. Then wells were washed three times in PBS prior to picric acid fix and crystal violet 493 
staining. Biofilm mechanism was investigated by treating mature biofilms with proteinase K 494 
(1mg/ml) or sodium periodate (40mM) for 24 hours prior to washing which digest protein 495 
and PIA dependent biofilms respectively..  496 
(B) C5a levels in controls and patients with PJI catagorised by biofilm accumulation 497 
mechanism. Results are expressed as the mean ± SEM C5a levels in sera from S. epidermidis 498 
PJI isolates (n=43). * represents a significant difference at P<0.05. 499 
 500 
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